Haemonetics HAE Business Segments
| TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|---|
| Net revenues by Business | ||||||
| Blood Center | $221.27M+0.2% | $220.86M-5.9% | $234.64M-4.9% | $246.72M-5.5% | $261.12M— | |
| Hospital | $588.3M+2.0% | $576.51M-0.1% | $576.99M+1.2% | $569.91M+1.0% | $564.27M— | |
| Plasma | $524.46M+0.7% | $520.9M+0.9% | $516.22M-2.5% | $529.42M-1.1% | $535.43M— | |
| Total net revenues by Product | ||||||
| Plasma | $524.46M+0.7% | $520.9M+0.9% | $516.22M-2.5% | $529.42M-1.1% | $535.43M-2.3% | |
| Net revenues by Geography | ||||||
| Europe | $185.02M+6.1% | $174.4M+2.4% | $170.29M+0.6% | $169.31M-3.6% | $175.66M+1.3% | |
| Japan | $68.2M+3.5% | $65.9M+3.1% | $63.94M+2.5% | $62.35M-0.1% | $62.41M+2.6% | |
| Other | $11.42M+3.1% | $11.08M-22.0% | $14.21M-10.0% | $15.79M-19.2% | $19.54M-2.7% | |
| Rest of Asia | $87.21M-1.3% | $88.4M-2.8% | $90.97M-3.4% | $94.17M+2.0% | $92.31M-5.8% | |
| United States | $982.18M+0.4% | $978.5M-1.0% | $988.45M-1.6% | $1B-0.6% | $1.01B+0.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Haemonetics break its business down?
- Haemonetics (HAE) reports net revenues by business across 3 parts — Blood Center, Hospital and Plasma. Each is extracted from the segment footnotes and tracked over time.
- Where does Haemonetics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Haemonetics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.